Adams Street Partners LLC Corvus Pharmaceuticals, Inc. Transaction History
Adams Street Partners LLC
- $101 Million
- Q1 2025
A detailed history of Adams Street Partners LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Adams Street Partners LLC holds 3,275,616 shares of CRVS stock, worth $14.1 Million. This represents 10.31% of its overall portfolio holdings.
Number of Shares
3,275,616
Previous 3,275,616
-0.0%
Holding current value
$14.1 Million
Previous $17 Million
38.85%
% of portfolio
10.31%
Previous 18.22%
Shares
3 transactions
Others Institutions Holding CRVS
# of Institutions
105Shares Held
36.7MCall Options Held
1.37MPut Options Held
338K-
Orbimed Advisors LLC San Diego, CA6.94MShares$29.9 Million0.69% of portfolio
-
Samlyn Capital, LLC New York, NY4.07MShares$17.5 Million0.21% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.79MShares$12 Million0.02% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$11.5 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$10.7 Million0.0% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $200M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...